Immune and in¯ammatory responses mediated by cytokines are essential in the pathophysiology of asthma. The aim of this study was to analyse the cytokine mRNA pro®les in bronchoalveolar lavage (BAL) cells of patients with mild atopic asthma, before and after induction of a subclinical allergic airway in¯ammation. For this purpose, eight patients with mild atopic asthma received low-dose allergen inhalations equivalent to 10% of a provocational dose causing a 20% fall in forced expiratory¯ow in 1 sec (PD 20 ) for 7 weekdays. BAL was performed before and after low-dose provocations in patients, and without provocation in ®ve healthy controls. Alveolar macrophages (AM) were enriched by negative selection, using magnetic beads, to enable separate studies of the BAL cells. Using a semiquantitative RT-PCR technique, the mRNA expression of macrophage-derived cytokines interleukin (IL)-1, IL-6, IL-8, IL-10, IL-12, IL-13, interferon (IFN)-g, tumour necrosis factor (TNF)-a and transforming growth factor (TGF)-b was analysed. After low-dose provocations, we observed a signi®cant increase in the expression of IL-13 mRNA (P=0Á01) in BAL cells enriched for AM of the asthmatic patients. The increased IL-13 mRNA positively correlated with the proportion of BAL¯uid eosinophils (r=0Á7, P=0Á05). Moreover, a tendency was found towards an increased IL-1 and a reduced IL-6, IL-8, IFN-g and TNF-a expression by the BAL cells. Comparing asthmatic patients before low-dose provocations and healthy controls, a signi®cantly higher expression of IL-6 (P50Á003), IL-10 (P50Á005) and TGF-b (P50Á003) and a signi®cantly lower expression of IL-8 (P50Á005) and TNF-a (P50Á01) was detected in the patients. In summary, repeated low-dose allergen provocations of asthmatic patients results in a modi®ed BAL cell cytokine mRNA pro®le with increased production of IL-13, that may be of importance for the development of a Th 2 -like immune response. A possible source of the increased IL-13 mRNA is AM, which may have a more active function in the allergic in¯ammation than previously thought.
Introduction
Bronchial asthma is a chronic in¯ammatory disease of the airways, in¯uenced by genetic and environmental factors, and characterized by bronchial hyperreactivity, eosinophil in®ltration, elevated serum IgE levels and excessive airway mucus production (1) . Bronchial in¯ammation re¯ects a cell-mediated immune process, in which cytokine production by activated T cells may orchestrate the immune response. Thus, the pathology of asthma is thought to be mediated primarily by the type 2 cytokines IL-4, IL-5 and IL-13 (2, 3) .
In animal models, IL-13 has been recently implicated in allergic asthma, acute lung in¯ammatory injury and pulmonary granuloma formation (4±7). IL-13 shares receptor components and biological properties with IL-4 such as induction of IgE synthesis and downregulation of IL-12 and IFN-g production, thereby favouring a type 2 cytokine response (8, 9) Repeated low-dose allergen exposure is a good method for studying the development of allergic in¯ammation in asthma. This model has been shown to provide a realistic gradual worsening of the asthmatic response with airway eosinophilia and increased IL-5 in induced sputum, associated with airway hyperresponsiveness without development of marked acute bronchoconstriction (10±12). In a recent study, we described an increased responsiveness to methacholine and airway in¯ammation after repeated lowdose allergen provocations in a group of patients with mild asthma (13) . In the present report, we used the same group of patients to analyse the mRNA cytokine expression in BAL cells enriched for alveolar macrophages (AM). We found a signi®cant increase in the expression of IL-13 mRNA, and a trend towards a reduced expression of the pro-in¯ammatory cytokines IL-6 and IL-8 and of the Th 1 associated cytokines IFN-g and TNF-a. Our results are in line with the notion that a repeated exposure for low doses of allergen elicits a Th 2 deviated immune response, and suggest the low-dose allergen provocation model to be appropriate for studies of early in¯ammatory events in allergic asthma.
Materials and methods

SUBJECTS
Eight patients with atopic asthma, seven females and one male, with a median age of 29 years (range 24±41 years) were included in the study. The patients had a history of mild allergic asthma to pollen and/or to animal dander with a positive skin prick test and positive radioallergoabsorbent test (RAST, Pharmacia, Uppsala, Sweden). All patients were in a stable phase of the disease with a median forced expiratory volume in 1 sec (FEV 1 ) 93% of the predicted normal value (range 80±101%) and median total IgE values of 79 kU l 71 (range 25±170 kU l 71 ). [For individual data see Lensmar et al. (13) .] No medication was taken except for occasional b 2 -agonists. All patients were free from symptoms of airway infection for at least 4 weeks prior to the study. The study was performed outside the pollen season and patients allergic to animal dander did not have pets, and were asked to avoid animal contact during the study period. Five healthy subjects (two females) without symptoms or a history of allergy, with a median age of 25 years (range 23±27 years) were selected as controls. The local Ethics Committee approved the study, and all patients gave informed consent.
STUDY DESIGN
A ®rst bronchoscopy with BAL was performed 2±3 weeks before starting the allergen provocation. Basal FEV 1 was measured before the ®rst dose of allergen as well as before and 15 min after each allergen inhalation. Allergen doses of birch or grass pollen (Aquagen, ALK, Copenhagen, Denmark) were selected according to previously determined PD 20 (the allergen dose causing 20% fall in FEV 1 ). Inhalation doses of allergen corresponding to 10% of PD 20 were administrated in the mornings, and at the same time daily during 7 weekdays [see Lensmar et al. (13) for more details]. The same dose was given every day and varied from 8Á4 SQ (arbitrary units related to the concentration of the allergen) to 243 SQ between the individuals. A second BAL was performed 1 day after completed allergen provocation. All bronchial provocations were performed by using a dosimeter controlled jet nebulized Spira Electro 2 (Respiratory Care Center, Hameenlinna, Finland). BAL was performed once in the Control group without any preceding provocation.
BAL AND AM PREPARATION
BAL was performed using a¯exible ®bre-optic bronchoscope (Olympus BF Type P20; Olympus Optical Co. Ltd, Tokyo, Japan) as previously described (14) . Brie¯y, the patients were pre-medicated with Morphine±Scopolamine (Pharmacia and Upjohn, Uppsula, Sweden) and administered inhaled b 2 -agonist 10 min before the bronchoscopy. The right middle lobe was instilled with ®ve aliquots of 50 ml sterile buered saline solution (PBS), and the¯uid was gently aspirated after each aliquot, collected in a sterile siliconized bottle and kept on ice. The lavage¯uid was ®ltered through a single layer of dacron net (type AP32, Millipore, Bedford, Ireland) and centrifuged at 400 g for 10 min at 4 o C. The cell pellet was resuspended in RMPI 1640 (Sigma-Aldrich Co, St Louis, MO, U.S.A.), counted in a BuÈ rker chamber and the viability assessed by cellular exclusion of trypan blue. Cytospin preparation was performed by centrifugation of 6610 4 cells at 500 g for 3 min (Cytospin 2, Shandon Southern Instruments, Runcorn, U.K.). One slide was stained in May±GruÈ nwald Giemsa for evaluation of cell dierentials, and another in Toluidine blue for assessment of metachromatic cell counts.
AM from BAL were enriched by negative selection using anti-CD2 coated magnetic beads (Dynalbeads, Dynal, Oslo, Norway) according to the manufacturer instructions, resulting in a depletion of T-lymphocytes and natural killer (NK) cells. The purity of this population was determined by May±GruÈ nwald Giemsa and Toluidine blue stainings.
RNA EXTRACTION, cDNA SYNTHESIS AND RT-PCR
Total cellular RNA was extracted from 1±2610 6 enriched AM with RNAzolB (Biotecx Labs, Houston, TX, U.S.A.) according to the manufacturer's instructions. The RNA was quantitated by spectrophotometry at 260 nm and stored at 7708 C. The integrity of the RNA sample was assessed by electrophoresis in a 1Á6% agarose gel (BRL, Gaithersburg, MD, U.S.A.) with 0Á2 mg ml 71 ethidium bromide.
RNA was denatured at 908 C for 5 min and chilled on ice. First strand cDNA synthesis was performed in a ®nal volume of 20 ml containing: 10 ml of denatured RNA (1±5 mg), 4 ml buer (56, BRL), 1Á5 ml dithiothretiol (100 mM, BRL), 2 ml dNTP (dATP, dCTP, dGTP and dTTP, 5mM each, Pharmacia, Uppsala, Sweden), 0Á5 ml RNasin (40U ml, Promega, Madison, W), 1Á0 ml random hexamer primers pd(N)6 (1 mM, Pharmacia) and 1Á0 ml reverse trancriptase from murine Moloney leukemia virus (200 U ml 71 , BRL).
The samples were incubated at 408C for 45 min and then heated for 5 min at 958C. The cDNA was ampli®ed by PCR in a 20 ml reaction mixture containing 2 ml of the target cDNA, 0Á25 mM primers, 2 mM MgCl 2 , 0Á2 mM dNTPs, 0Á025 U ml 71 Taq polymerase (Sigma) using a GeneAmp PCR System 9600 (Perkin Elmer, Norwalk, CT, U.S.A.). An appropriate dilution of the cDNA samples and the number of cycles for each primer were chosen after preliminary experiments, ensuring that the samples remained within the exponential range of ampli®cation (data not shown). The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (G3PDH) was used to check the quality of the cDNA preparation as well to normalize the cDNA concentrations. The expression of each cytokine was calculated in relation to G3PDH expression. The cytokines and primer sequences used are shown in Table 1 .
PCR was conducted for 30±40 cycles under the following conditions: denaturation at 948C, annealing at 628C for cytokines (558C for G3PDH), and extension at 728C. IL-1, IL-6, IL-10, IL-12, IL-13 and TNF-a primers were synthesized on a DNA Synthesizer (Applied Biosystem, Foster City, CA, U.S.A.) while IL-8, IFN-g, TGF-b and G3PDH primers were purchased from Clontech (Palo Alto, CA, U.S.A.). Phytohaemagglutinin stimulated mononuclear cells expressed all cytokines tested for, and thus served as a positive control to ascertain that each primer yielded a PCR product of the correct size (data not shown). The PCR products were visualized on a 1Á6% agarose gel containing 0Á2 mg ml 71 ethidium bromide, and analysed using a DC120
Zoom Digital Camera connected to ID Image Analysis Software (Kodak, Eastman Kodak Co. Rochester, NY, U.S.A.). The relative mRNA levels were expressed as the ratio of the net intensity detected in a given cytokine band divided by that of its respective G3PDH band. The speci®city of ampli®ed PCR products for G3PDH and IL-13 was con®rmed by Southern blot and hybridization with 32 P-labelled speci®c probes, according to standard protocols. Radioactive products were scanned and analysed in a Phosphoimager (Molecular Dynamics, U.S.A.).
STATISTICAL ANALYSIS
The Mann±Whitney U-test and the Wilcoxon matched pairs test were used for intergroup and intragroup comparisons, respectively. Correlations were calculated using Spearman rank correlation test. A P-value of less than 0Á05 was considered statistically signi®cant.
Results
PATIENTS AND BAL SAMPLES
After 7 weekdays of repeated low dose allergen provocations, an allergic in¯ammatory reaction, subclinical in six out of eight asthmatic subjects, was observed as determined by increased airway methacholine reactivity, increased BAL uid total cell and eosinophil counts and increased serum eosinophilic cationic protein (ECP) levels. Detailed data are 
CYTOKINE mRNA EXPRESSION BEFORE AND AFTER LOW-DOSE ALLERGEN
A semiquantitative RT-PCR was performed to analyse cytokine mRNA expression, using mRNA of the housekeeping gene G3PDH to enable comparisons of each cytokine mRNA transcript expression in BAL samples before and after provocation [ Fig. 1(a) ]. The expression of IL-13 mRNA was found to be statistically signi®cantly enhanced (P=0Á01). IL-13 transcripts were detected only in two out of the eight asthmatics (2/8) before provocation and were found to be upregulated in all eight patients after provocation [ Fig. 1(a and b) ]. In three of the patients, the speci®city for IL-13 on the ampli®ed PCR material was investigated and con®rmed by probing transferred products with an IL-13 probe complementary to sequences internal to the primers [ Fig. 1(c) ]. A tendency was observed to a reduced mRNA expression for IFN-g (7/8), IL-6 (6/8), IL-8 (6/8) and TNF-a (5/8) and to an increased expression of mRNA for IL-1 (5/8) after the allergen provocations (Fig. 2) . Finally, IL-10, IL-12 and TGFb mRNA were detected but without any distinct patterns before or after provocation. The post-challenge increase in the expression of IL-13 showed a positive correlation with the increased BAL¯uid proportion of eosinophils (P=0Á05, r=0Á7), (Fig. 4) and with the serum ECP values (P=0Á09, r=0Á7), although a signi®cant P-value was obtained only with the former parameter. A signi®cant positive correlation was also found between the post-challenge change in BAL cell concentration and proportion of neutrophils and the change in IL-8 mRNA expression (P=0Á002, r=0Á9 and P=0Á01, r=0Á8, respectively).
CYTOKINE mRNA EXPRESSION IN PATIENTS VERSUS HEALTHY CONTROLS
A signi®cantly higher mRNA expression for IL-6 (P=0Á003), IL-10 (P=0Á005) and TGF-b (P=0Á003) was found in patients (before allergen provocation) vs. controls [ Fig. 3(a) ], while IL-8 (P=0Á003) and TNF-a (P=0Á008) mRNA transcripts were signi®cantly lower in the former group [Fig 3(b) ]. The same pattern of cytokine expression was observed when comparing the asthmatics after provocation with healthy controls, except for IL-13 that was signi®cantly higher (P=0Á005) expressed in asthmatics than in controls but only after low-dose allergen provocation. No signi®cant dierences were observed in the mRNA expression of IL-1, IL-12, IL-13 and IFN-g cytokines between the two groups.
Discussion
Low-dose allergen provocation has proven to be a useful model for studying airway hyperresponsiveness as well as the in¯ammatory process underlying mild bronchial asthma (10±12). Recently, we demonstrated a subclinical in¯am-matory reaction after low-dose provocation in a group of mild atopic asthmatic patients (13) . In the present study, The enhanced in vitro production of immunoglobulin E (IgE) observed in asthmatic patients has been reported to be mediated by IL-13, and therefore IL-13 may play a central role in the pathogenesis of IgE-mediated allergic diseases (15, 16) . The upregulation of IL-13 transcripts in BAL cells of patients with mild asthma after low-dose allergen provocations, as reported here, is in good agreement with the recently demonstrated elevated expression of IL-13 mRNA in the bronchial mucosa of patients with asthma (17) . IL-13 selectively induces vascular cell adhesion molecule (VCAM)-1 expression on endothelial cells, favouring a VCAM-1/very late antigen (VLA)-4 dependent accumulation of in¯ammatory cells at the site of the in¯ammatory reaction (18, 19) . Moreover, IL-13 enhances survival of eosinophils and may contribute to the pathological activities of these cells in asthma (20) . In line with these reports, we found a positive correlation between the post-challenge increase in the proportion of eosinophils and the elevated IL-13 mRNA expression. Besides cell in®ltration, IL-13 may also be important for airway obstruction (21) , as shown by blocking or adding IL-13 in experimental animal models (4, 5) .
In particular T lymphocytes, but also mast cells, basophilic granulocytes and dendritic cells, are capable of producing IL-13 (22±24). On the other hand, human eosinophils are not considered as a source of IL-13 (25) . In our study, the vast majority (497 %) of BAL cells were AM, which only recently were recognized as a potential source of IL-13 (26) . We found no correlation between the numbers of contaminating cells and the increased IL-13 mRNA expression, and suggest that AM may be the source of the elevated IL-13 mRNA expression following lowdose allergen provocations. To con®rm such an IL-13 production by AM, one could apply in situ hybridization techniques, something we were unable to perform in this study due to lack of material.
Many biological activities of IL-13 are shared with IL-4, probably due to the common IL4Ra chain for IL4R and IL-13R, required for signal transduction (4, 8, 27) . IL-13 may aect T cell functions and Th 2 -cell dierentiation indirectly through its downregulatory eects on the production of IL-12, IFN-g and TNF-a (9, 28) . This observation is in agreement with the decreased expression of IFN-g transcripts in our study. Although IFN-g expression has previously been considered to be restricted to T and NK cells, unstimulated or IL-12-stimulated AM as well as AM from tuberculosis patients have been shown to produce and secrete IFN-g (29, 30) . Also the downregulation of the pro-in¯ammatory cytokines IL-6 and TNF-a and the chemokine IL-8 after low-dose inhalations may be due to the inhibitory capacity of IL-13 on the monocyte/ macrophage production of cytokines (6, 8) .
In the BAL cells of patients before allergen challenge vs. controls, there was a signi®cantly higher expression of the Th 2 associated cytokines IL-6 and IL-10, as well as of TGF-b that has been implicated in airway wall remodelling activity in asthma. In contrast, the cytokines IL-8 and TNF-a were expressed at lower levels in asthmatics than in controls. Our results are in line with previous reports showing an increased expression of IL-10 mRNA in BAL uid from asthmatics, an inhibitory capacity of IL-10 on macrophage cytokine production and increased levels of TGF-b in BAL¯uid from asthmatics (31±34).
In summary, the cytokine pattern in BAL cells from patients with mild atopic asthma after repeated low-dose allergen provocations is characterized by a signi®cant IL-13 upregulation and an IFN-g downregulation in addition to an inhibition of pro-in¯ammatory cytokine expression, i.e in part a Th 2 deviated immune response. Although the origin of IL-13 was not ®rmly established in this study, AM is a possible source as they made up 497 % of the investigated cells. This could indicate that AM play a more regulatory role in the pathogenesis of allergic asthma than previously believed.
